Robert Wilson

An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male Subjects

W. Fahy, C. Beaumont, A. Harrell, 2019, Drug Metabolism and Disposition.

Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD.

H. Watz, A. Kirsten, S. Sriskantharajah, 2017, Pulmonary pharmacology & therapeutics.

Exploring PI3Kδ Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled Trials

M. Lennon, F. Maltais, J. Bourbeau, 2021, International journal of chronic obstructive pulmonary disease.

COPD_A_309303 1621..1636

Cahn, M. Lennon, F. Maltais, 2021 .

Localization of artesunate and its derivatives in the pregnant rat and fetus following oral administration and relationship to developmental toxicity.

R. Clark, A. Harrell, Robert Wilson, 2010, Birth defects research. Part B, Developmental and reproductive toxicology.

A nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot study

G. Perkins, D. Thickett, D. McAuley, 2020, European Journal of Anaesthesiology.

Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury

M. Hind, R. D. de Wildt, M. Griffiths, 2018, Thorax.

The Role of Tumor Necrosis Factor-α in Liver Toxicity, Inflammation, and Fibrosis Induced by Carbon Tetrachloride

M. Luster, P. Simeonova, C. Kommineni, 2001 .